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Abstract 
Introduction: The new contract for primary care mandates that all practices use a 
screening tool, such as the Electronic Frailty Index (EFI) to screen for frailty and apply 
clinical judgement, based on knowledge of the patient, to decide if they have a diagnosis 
of frailty. However, whilst EFI predicts hospitalisation, institutionalisation, and mortality, 
it has not been validated as a screening tool for frailty.  
In primary care, home visits are performed when a clinician determines that a patient is 
housebound; they are functionally impaired to the point that it is unreasonable to expect 
them to attend surgery. Anecdotally, many of these patients have a diagnosis of frailty. 
This study assessed whether a clinician’s judgement that clinical encounters could only 
take place by home visit could, in itself, form a new screening tool for frailty. 
Method: A retrospective analysis was performed of 154 patient’s medical records from 
1/3/15 to 29/2/16 who were aged 65 years and over at the start of the study. Patients 
were divided into two groups. The first group (n=82) had received a home visit, and the 
second group consisted of a randomised sample of patients (n=72) with similar baseline 
characteristics, who had not had a home visit. Patient records were analysed by two 
clinicians to determine whether a frailty syndrome was present. Researchers were 
blinded to each other’s results. An arbitrator determined the frailty status on 
disagreement. The data was statistically analysed to give the sensitivity, specificity, 
positive and negative predictive values of home visits as a screen for frailty.  
Results: As a screening tool for frailty, home visits have a sensitivity of 87.23% (95% CI: 
74.35% to 95.17%) and specificity of 61.68% (95% CI: 51.78 to 70.92%). Cohen’s Kappa 
showed fair inter-observer reliability. 
Conclusion: The results show home visits are a good screen for frailty. Furthermore, it 
does not require any additional time to perform. Knowledge of this will make clinicians 
undertaking home visits more alert to the possibility that the patient has a diagnosis of 
frailty and will speed up diagnosis and treatment.  
 
Introduction 
Frailty is a clinically recognised state of increased vulnerability, resulting from ageing and 
associated with a decline in physiological reserve1. A long-term condition in its own right, 
patients with frailty are at dramatic risk of deterioration after seemingly minor 
physiological insults1.  
In the UK 18% of the population are 65 years or older 2.4% of the population are 85 years 
or older2. Studies in the UK and the USA have shown an overall frailty prevalence of 6-
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14% in 65+ year olds3,4. However these studies demonstrate that the prevalence of frailty 
exponentially increases with age, such that in those aged 60 to 69 years the frailty 
prevalence is 3.2-6.5%; increasing to 25-30% in 80-89 year olds; but could be anywhere 
between 25-60% in those over 90 years3,4. This is a problem that is set to grow, with the 
proportion of 65+ year olds almost doubling by 2036 in the UK2. 
Older people with frailty have a substantially increased risk of poor health outcomes such 
as falls, hospitalisation, disability, long-term care, and death3,4,5. Diagnosis is crucial as it 
enables interventions to take place that improve outcomes such as the Comprehensive 
Geriatric Assessment and information sharing amongst the different providers involved 
in patient care1. Furthermore, patients with frailty are much more likely to have adverse 
events from medical interventions, such as starting a new drug or surgery. Knowledge of 
frailty may make a clinician think twice about certain interventions, enabling more 
informed decision-making.  
There are two models for identifying frailty. The first is the frailty “phenotype” model4 
which defined frailty as with three or more out of the five characteristics: unintentional 
weight loss (10lb in the past year), self-reported exhaustion, weakness (grip strength), 
slow walking speed, and low physical activity4. The second model is the Cumulative deficit 
model proposed by Rockwood et al6, which is based on counting the number of clinical 
deficits (symptoms, signs, conditions, and biochemical values) and using certain cut offs 
to base a diagnosis of frailty on. Both have independently predicted falls, disability, 
hospitalisation, institutionalisation, and death.  
However, these models are not always practical in primary care. The phenotype model is 
time consuming and requires equipment and trained personnel that are not found in 
primary care.  At the time of embarking upon this study the cumulative deficit model had 
not been embedded into primary care IT systems, confining it to the research setting as 
well4,6.  
There is another key point to note with these models; the patients in both models were 
diagnosed with frailty on the grounds that they had an increased probability of falls, 
hospitalisation, institutionalisation and death4,6. However, having an increased 
probability of the above outcomes does not inevitably mean the patient is frail. For 
example, patients with incurable cancer will all have an increased probability of falls, 
mortality, hospitalisation, institutionalisation and death. Some may have co-existing 
frailty. Many may not. There is also a dissonance in these models between the definition 
of frailty- a state of reduced physiological reserve where minor stressors trigger a 
dramatic deterioration in function- and the diagnostic criteria for frailty. One might reflect 
that to meet the definition for frailty the patient must suffer an acute functional decline 
from a minor stressor or be judged to be at high risk of an acute functional decline from 
minor stressors. This is different to looking at a cohort of patients in the Cardiovascular 
Health Study in the US4 and the Canadian Study of Health and Ageing6, applying diagnostic 
criteria, and evaluating if this increases probability of falls, mortality, hospitalisation, 
institutionalisation and death.  
In 2014, the British Geriatric Society (BGS) offered a more intuitive way to think about 
frailty1. They suggested five frailty syndromes, that if present (and the clinical picture fit), 
should make a clinician strongly consider a diagnosis of frailty. These syndromes include 
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recurrent falls, acute or worsening immobility, acute or worsening incontinence, 
delirium, and susceptibility to side effects of multiple medications1.  
To clinicians the ‘syndrome approach’ to frailty makes sense and is best illustrated using 
falls as an example. The ability of a person to remain upright is the result of complex, 
highly integrated feedback pathways, across multiple body systems. Massive quantities 
of information are relayed across different parts of the body, enabling micro-adjustments 
to be made to the position of body in 3D space, keeping it upright. It follows that if there 
are impairments in multiple body systems, the probability of falling increases. When there 
is a ‘critical mass’ of impairments, the human body will not be able to maintain its position 
in 3D space and a fall will result (the ‘falls threshold’). Patients who are near their falls 
threshold clearly have reduced compensatory mechanisms across multiple systems, 
meaning that a minor stressor will trigger the fall. This is the definition of frailty. 
Furthermore, there are studies demonstrating outcomes of hospitalisation, 
institutionalisation, morbidity and mortality in older people with falls7,8,9, delirium10,11, 
incontinence12  immobility13,14, and adverse drug reactions15. 
BGS also advocated screening tests for frailty. Examples include PRISMA 7 (sensitivity 
83%, specificity 83%), gait speed (sensitivity 99%, specificity 64%), and timed get-up-
and-go-test of 10 seconds (sensitivity 93%, specificity 62%)16. However, these tests were 
compared against Phenotype model as the reference test. This had a slightly lower frailty 
prevalence than other studies3,4 and, as discussed earlier, is slightly challenged in terms 
of diagnosing “true frailty” as per its definition. PRISMA 7, gait speed and timed-up-and-
go test are seldom used in primary care due to the demands on clinician time. 
In 2017, NHS England included frailty as a feature in the new primary care contract. GP 
surgeries were to use the Electronic frailty Index (EFI), or other validated tools, as a 
method to screen for frailty and code patients accordingly17. EFI is based on the 
Cumulative Deficit Model of frailty; as co-morbidity increases the probability of frailty 
increases18. There are 36 conditions (mostly diseases), each given a score of one, which is 
summed, then decimalised.  For example, if a patient has one condition, they score 1/36. 
If they have three conditions they score 3/36 and so on. The scores are decimalised and 
if the EFI score is 0.24-0.36, the patient is said to have “moderate frailty.” Higher than 
0.36, patients are said to have “severe frailty18.” It should be emphasised that the terms 
‘moderate’ or ‘severe’ frailty in this context are misnomers; they categorisations 
according to EFI rather than diagnoses of frailty. 
This is recognised in the primary care contract and as a result, required general 
practitioners to create a list of patients in their surgeries with moderate and severe frailty 
and then apply clinical judgement to determine if they are actually severely frail17. 
However, there are problems with this model of care. EFI will only return a moderate or 
severe score if a patient has a certain number of deficits. Some patients with very few 
deficits may have severe frailty. For example, a patient with advanced dementia, in a 
nursing home, and dependent on care will return and EFI score of 4/36 or 0.11, and would 
be classified as not frail. This patient may well have coexisting frailty (as per the definition 
of frailty) yet not feature on the list of patients created by EFI.   
This is an accepted authors draft of a paper published in Journal of Family Medicine and Primary Care  
Online publication complete SEP-2018  
DOI: 10.4103/jfmpc.jfmpc_159_18 
 
Furthermore, as EFI has not been validated as a screen for frailty there is the possibility 
that EFI scores of frailty may not necessarily mean there is a clinical diagnosis of frailty.  
There is a clear need in primary care for an easy to administer screen for frailty and in 
this study we investigate the possibility of using a simple solution that is routinely 
performed by on clinicians. In primary care, home visits are only performed when a 
clinician judges that a patient is housebound; they are functionally impaired to the point 
that it is unreasonable to expect them to attend surgery. Anecdotally, it is possible that 
many of these patients could have a diagnosis of frailty. This study assessed whether the 
need for a home visit, could in itself, form a new screening tool for frailty. 
 
Method: 
The study participants were registered at a General Practice (GP) surgery in Devon, 
between 1st March 2015 and 29th February 2016. The GP surgery was in the fourth more 
deprived decile on the Index of Multiple Deprivation (IMD) score and during this period 
there was approximately 3,000 registered patients, of which 470 (15%) were aged 65 
years and over.   
A home visit group (n=82), was identified, containing all the patients who had received a 
home visit during the study period. This was compared against a randomly selected 
sample of patients (n=72) with similar baseline characteristics who had not had a home 
visit. This was achieved by stratifying the home visit patients by sex (male versus female) 
and age cohorts. Random selection was achieved using a random numbers generator.  
Two clinicians independently examined the medical records of each of the sampled 
patients’ for the defined study period to see if one or more of the BGS frailty syndromes 
were present. If a frailty syndrome was found, clinical judgement was applied to 
determine of the patient had a diagnosis of frailty. If they did, they were recorded as such. 
This meant that the BGS frailty syndromes were used as the reference test. 
One clinician was employed by the GP surgery and could not be blinded to whether the 
patient had a home visit during the study period. The second clinician was independent 
of the GP surgery and had no knowledge whether a patient had a home visit during the 
study period. If there was a disagreement between the two clinicians of the patient’s 
frailty diagnosis, a third clinician (arbitrator), who worked at the practice, was asked to 
review the patient’s medical records and determine their frailty diagnosis. All clinicians 
were blinded to each other’s diagnosis of frailty. 
The results were analysed using the statistical software Stata version 1419. Inter-rater 
reliability was assessed using Cohen’s Kappa statistic. However, the 95% confidence 
intervals (CI) for the sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) were calculated in the statistical software R20 using the package 
bdpv21.  
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Due to the sampling method used in this study, it was possible that the proportion of 
participants who were diagnosed as frail were not representative of the actual proportion 
of frail patients within the practice. Therefore, to calculate the PPV and NPV we 
considered the prevalence estimates from the English Longitudinal Study of Aging 
(ELSA)3 for 65 years and over, which was 14% (95% confidence interval: 12% to 16%) 
based on 5450 participants. 
Results: 
Baseline characteristics are shown in table 1. As patients who did not have a home visit 
were randomly selected to ensure these groups were balanced by age and sex, there was 
reasonable balance in the numbers frequencies and proportions by home visit. This was 
also true within the clinician diagnosis of frailty, where there appeared to be reasonable 
agreement by age, but less by sex. 
 
Demographics Clinician Diagnosis Home Visit 
Not Frail 
(n = 107) 
Frail 
(n = 47) 
No 
(n = 72) 
Yes 
(n = 82) 
Age in years     
Mean (SD) 80 (7.9) 84 (6.8) 80 (7.2) 83 (8.2) 
Gender n (%)     
 Male 29 (67.4) 14 (32.56) 21 (48.8) 22 (51.2) 
 Female 78 (70.3) 33 (29.7) 51 (46.0) 60 (54.1) 
Table 1: Characteristics of patients in each group 
When comparing the presence of the number of frailty syndromes between the two 
original clinicians, the agreement was 68.2% (105 patients) with a kappa coefficient of 
0.40. When comparing the binary outcome of clinical diagnosis of frailty (i.e. a patient has 
at least 1 frailty syndromes), the agreement was 81.2% (125 patients) and the kappa 
coefficient was 0.58. Essentially the evidence suggests there is fair agreement between 
the two clinicians. 
 
Frequency Home Visit Total 
No Yes 
Clinician 
Diagnosis 
No 66 41 107 
Yes 6 41 47 
Total 72 82 154 
Table 2: A table comparing the proportion of those with a clinical diagnosis of 
frailty and home visits. 
The results in table 2 compare the clinical diagnosis of frailty with home visits. The values 
in the table are based on the arbitrated scores. The sensitivity was estimated as 87.23% 
(95% CI: 74.35% to 95.17%) and the specificity was 61.68% (95% CI: 51.78 to 70.92%). 
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To estimate the PPV and NNP, we used the estimates from ELSA study3, as we believed 
these values were more representative of the English population where this screening 
tool would be applied to. Table 3 shows the estimates for the NPV and PPV for the 
prevalence’s reported. The NPV appears to decrease as the prevalence increases, whereas 
the PPV increases as the prevalence increases. 
ELSA Prevalence 
Group 
NPV PPV 
Est. 95% CI Est 95% CI 
60 years or over 
(14%) 
96.7 (93.3 to 98.5) 27.0 (22.2 to 32.6) 
60-69 years  
(6.5%) 
98.6 (97.0 to 99.3) 13.7 (10.8 to 17.1) 
90 years or over 
(65%) 
72.2 (54.8 to 84.8) 80.9 (76.5 to 84.6) 
Table 3: Negative and positive predictive values using the estimated prevalence 
from the ELSA study. 
 
Discussion: 
The results show that home visits offer an 87.2% sensitivity and 61.7% specificity, which 
compares favourably with other screening tools available such as PRISMA 7 (sensitivity 
83%, specificity 83%), gait speed (sensitivity 99%, specificity 64%), and timed get-up-
and-go-test of 10 s (sensitivity 93%, specificity 62%)6. Even if the lower confidence 
intervals (sensitivity 74% and specificity 52%) are correct, this test requires no 
examination, questionnaire, or scoring system and is easy to administer: the simple act of 
a GP making the decision to home visit a patient could automatically act as a mental 
prompt to evaluate for frailty. This would confer numerous benefits such as speeding up 
the diagnosis and initiation/referral for key interventions which are proven to improve 
clinical outcomes such as the Comprehensive Geriatric Assessment (CGA)1. The 
population assessed in the study were representative of most of the rest of the UK. 
The change in NPV and PPV would indicate that any interpretation and subsequent action 
by clinicians may be dependent on the patient’s age. However, as the study is based on a 
relatively small sample of participants and the age range did not match the ELSA study, 
these estimates should be viewed with caution. Especially for the NPV of 90 years or over, 
as the 95% CI was 55 to 85%. 
Using home visits as a screen for frailty is intuitive as the need for a home visit is based 
on a clinician’s judgement that the patient has reduced physical function. Given that frailty 
is defined as a state of reduced physiological reserve, it seems highly probable that 
patients requiring a home visit have co-existing frailty.  
This screen offers increased utility in a secondary care setting. For example, a GP referral 
that starts with “Many thanks for seeing this patient who has had three home visits in the 
last two months…” increases the index of suspicion for a frailty syndrome. Another 
example is in Orthogeriatrics, where knowledge of previous home visits might make a 
clinician’s more wary of the potential for a dramatic deterioration following an admission 
for fractured neck of femur.  
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The study showed some variation in inter-observer reliability with a Cohen’s Kappa that 
showed fair agreement. Two factors accounted for this. Firstly none of the patients had a 
coded diagnosis of frailty. This necessitated two clinicians retrospectively analysing and 
interpreting primary care clinician’s notes and deciding whether a frailty syndrome 
existed. Making that judgement was sometimes challenging and is perhaps easier to 
accomplish prospectively rather than retrospectively. In addition, one clinician knew the 
patients home visiting status, which may bias results. 
The study was also limited in that it only assessed for frailty during the study time period. 
In several subjects, frailty phenotypes had been noted in the few years prior to this but 
were not included in the study and discounted from analysis.  
Another potential limitation was assessing for frailty using the five clinical syndromes. 
Frailty is defined as a state of increased vulnerability due to a decline in physiological 
reserve and the direct care teams felt that several patients met this definition of frailty 
but did not exhibit one of the five clinical syndromes. For example, one patient in the home 
visit group was bedbound (no falls and no new/worsening immobility as already 
immobile), catheterised (so no worsening/new incontinence) and did not have any other 
frailty syndromes. They were classified according to study criteria as not frail. 
Another difference between this screen and a previous systematic review of screening 
tests16 is that the phenotype model4 was used as the reference standard. This study 
employed the BGS guidelines frailty syndromes as the reference standard1.  
 
Conclusion: 
This exploratory study demonstrates that if a primary care clinician decides that a patient 
requires a home visit, this same judgement can be used as a screening tool for frailty, with 
a sensitivity and specificity that is comparable to some of the current screens for frailty. 
However, as this data is routinely gathered, there is no extra time burden to GP’s or their 
computational systems needed and it also flags to patients who may require further 
assessment to diagnose Frailty.  
Whilst the EFI score and the phenotype model have traditionally been used as reference 
standards for frailty, they do not actually diagnose the acute functional decline or the 
potential for an acute functional decline that is the defining feature of frailty. Although 
they do have a role in predicting outcomes such as falls, hospitalisation, 
institutionalisation morbidity, and mortality.  
The authors would suggest that the British Geriatric Society’s guideline on using frailty 
syndromes to diagnose frailty is intuitive. However, in addition to the five syndromes, we 
would suggest adding a sixth; that a clinician who has knowledge of the patient judges 
them to have reduced physiological reserve and is at risk of a dramatic deterioration in 
function. 
It would strengthen the validity of the results to look across multiple GP practices to see 
if the study findings are generalisable, and to compare home visits against EFI as a screen 
for frailty. In addition it would be interesting to evaluate the BGS frailty syndromes using 
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similar methodology and outcomes to the phenotype and cumulative deficit model to 
demonstrate non-inferiority.  
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